335 related articles for article (PubMed ID: 29334687)
1. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
Proebstl L; Kamp F; Koller G; Soyka M
Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence.
Stock AK; Rädle M; Beste C
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():41-52. PubMed ID: 29953935
[TBL] [Abstract][Full Text] [Related]
3. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
van Gorp WG; Hinkin CH
Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716
[No Abstract] [Full Text] [Related]
4. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
Kalechstein AD; Newton TF; Green M
J Neuropsychiatry Clin Neurosci; 2003; 15(2):215-20. PubMed ID: 12724464
[TBL] [Abstract][Full Text] [Related]
5. Does elevated peripheral benzodiazepine receptor gene expression relate to cognitive deficits in methamphetamine dependence?
Veerasakul S; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S
Hum Psychopharmacol; 2016 May; 31(3):243-6. PubMed ID: 26913858
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder.
Basterfield C; Hester R; Bowden SC
Neuropsychology; 2019 Jul; 33(5):739-753. PubMed ID: 31021107
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine and meth mouth: an overview.
Williams N; Covington JS
J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
[No Abstract] [Full Text] [Related]
8. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
Stock AK; Beste C
Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
[No Abstract] [Full Text] [Related]
9. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users.
Chana G; Everall IP; Crews L; Langford D; Adame A; Grant I; Cherner M; Lazzaretto D; Heaton R; Ellis R; Masliah E;
Neurology; 2006 Oct; 67(8):1486-9. PubMed ID: 17060582
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine and cardiovascular pathology: a review of the evidence.
Kaye S; McKetin R; Duflou J; Darke S
Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
[TBL] [Abstract][Full Text] [Related]
11. Meth mouth.
Heng CK; Badner VM; Schiop LA
N Y State Dent J; 2008; 74(5):50-1. PubMed ID: 18982966
[TBL] [Abstract][Full Text] [Related]
12. Meth mouth: a national scourge.
Mallatt ME
J Indiana Dent Assoc; 2005; 84(3):28-9. PubMed ID: 16359093
[No Abstract] [Full Text] [Related]
13. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.
Sim T; Simon SL; Domier CP; Richardson K; Rawson RA; Ling W
J Addict Dis; 2002; 21(1):75-89. PubMed ID: 11831502
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-induced neural and cognitive changes in rodents.
Marshall JF; Belcher AM; Feinstein EM; O'Dell SJ
Addiction; 2007 Apr; 102 Suppl 1():61-9. PubMed ID: 17493054
[TBL] [Abstract][Full Text] [Related]
15. Is methamphetamine abuse a risk factor in parkinsonism?
Guilarte TR
Neurotoxicology; 2001 Dec; 22(6):725-31. PubMed ID: 11829406
[TBL] [Abstract][Full Text] [Related]
16. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary arterial hypertension seen in methamphetamine abusers.
Thompson CA
Am J Health Syst Pharm; 2008 Jun; 65(12):1109-10. PubMed ID: 18541676
[No Abstract] [Full Text] [Related]
18. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
Volz TJ; Fleckenstein AE; Hanson GR
Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
[TBL] [Abstract][Full Text] [Related]
19. Memory impairment in methamphetamine dependent patients.
Moon M; Do KS; Park J; Kim D
Int J Neurosci; 2007 Jan; 117(1):1-9. PubMed ID: 17365096
[TBL] [Abstract][Full Text] [Related]
20. Corticolimbic dysregulation and chronic methamphetamine abuse.
Baicy K; London ED
Addiction; 2007 Apr; 102 Suppl 1():5-15. PubMed ID: 17493049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
